Multiepitope CD8(+) T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting.
Dutoit V, Taub RN, Papadopoulos KP, Talbot S, Keohan ML, Brehm M, Gnjatic S, Harris PE, Bisikirska B, Guillaume P, Cerottini JC, Hesdorffer CS, Old LJ, Valmori D.
Dutoit V, et al. Among authors: bisikirska b.
J Clin Invest. 2002 Dec;110(12):1813-22. doi: 10.1172/JCI16428.
J Clin Invest. 2002.
PMID: 12488431
Free PMC article.